FibroGen Inc.

NASDAQ: FGEN · Real-Time Price · USD
9.49
0.01 (0.11%)
At close: Aug 15, 2025, 3:59 PM
9.44
-0.58%
After-hours: Aug 15, 2025, 07:24 PM EDT

FibroGen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.35M 2.74M -123.26M 46.33M 50.64M 25.36M 27.14M 40.13M 44.32M 36.16M 34.37M 15.73M 29.81M 60.83M 16.54M 155.97M 24.36M 38.43M
Cost of Revenue
85K 252K -20.67M 5.29M 5.18M 21.34M 5.41M 4.24M 5.71M 3.49M 4.92M 4.31M 6.81M 4.24M 3.13M 3.27M 3.08M 3.4M
Gross Profit
1.26M 2.49M -102.59M 41.04M 45.46M 4.02M 21.73M 35.89M 38.61M 32.67M 29.44M 11.43M 23M 56.59M 13.42M 152.71M 21.29M 35.03M
Operating Income
-12.05M -14.92M -73.54M -16.78M -10.92M -49.18M -95.1M -63.48M -88.05M -76.09M -66.15M -93.66M -78.22M -62.99M -135.24M 50.97M -133.84M -70.43M
Interest Income
286K 413K n/a 3.8M -945K 2.23M 2.5M 4.3M 2.65M 1.04M 924K 1.8M 5.2M 320K 1.04M 342K 562K n/a
Pretax Income
-13.78M -16.76M -69.38M -17.97M -15.81M -49.04M -93.12M -63.53M -88.47M -77.43M -66.35M -91.94M -73.17M -63.41M -134.31M 49.56M -134.55M -71.38M
Net Income
-7.6M 4.64M 17.98M -17.08M -15.54M -32.93M -56.23M -63.62M -87.68M -76.7M -66.45M -91.65M -73.19M -63.52M -134.08M 49.8M -133.99M -71.75M
Selling & General & Admin
7.06M 8.11M -13.32M 17.55M 22.28M 16.71M 24.22M 25.57M 31.18M 34.27M 33.97M 29.9M 30.26M 30.56M 34.74M 25.85M 32.55M 30.78M
Research & Development
5.87M 9.18M 1.49M 21.71M 34.11M 36.49M 51.7M 61.19M 95.48M 74.49M 61.63M 75.18M 70.96M 89.02M 113.92M 75.88M 122.57M 74.68M
Other Expenses
393K 126K 900K 18.55M n/a n/a n/a 12.61M n/a n/a n/a n/a n/a n/a n/a n/a n/a -453K
Operating Expenses
13.31M 17.41M -10.93M 57.82M 56.38M 53.2M 75.93M 99.37M 126.66M 108.76M 95.59M 105.08M 101.22M 119.58M 148.66M 101.73M 155.12M 105.45M
Interest Expense
2.01M 2.26M 2.22M 4.99M 6.06M 2.09M 5.07M 5.02M 3.07M 2.37M 1.12M 84K 141K 419K 110K 1.41M 718K 501K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
13.4M 17.66M -31.6M 63.11M 61.56M 74.55M 81.33M 103.62M 132.37M 112.25M 100.52M 109.39M 108.03M 123.82M 151.78M 105M 158.2M 108.86M
Income Tax Expense
-92K 2K 2K 12K -262K 7K -175K 84K -235K 74K 108K 114K 23K 113K 112K 106K -3K 134K
Shares Outstanding (Basic)
4.04M 100.95M 100.83M 100.52M 99.83M 98.98M 98.5M 98.25M 97.73M 94.69M 94.03M 93.77M 93.47M 93.04M 92.69M 92.64M 92.28M 91.69M
Shares Outstanding (Diluted)
4.04M 100.95M 100.83M 100.52M 99.83M 98.98M 98.5M 98.25M 97.73M 94.69M 94.03M 93.77M 93.47M 93.04M 92.77M 92.81M 92.28M 91.69M
EPS (Basic)
-1.88 0.05 0.18 -0.17 -0.16 -0.33 -0.57 -0.65 -0.9 -0.81 -0.71 -0.98 -0.78 -0.68 -1.45 0.54 -1.45 -0.78
EPS (Diluted)
-1.88 0.05 0.18 -0.17 -0.16 -0.33 -0.57 -0.65 -0.9 -0.81 -0.71 -0.98 -0.78 -0.68 -1.45 0.54 -1.45 -0.78
EBITDA
-11.54M -14.18M -91.1M -12.24M -10.14M -46.13M -49.82M -56.81M -82.68M -72.09M -62.54M -89.18M -70.37M -60.41M -132.66M 53.56M -129.54M -65.09M
EBIT
-11.77M -14.51M -91.45M -12.98M -10.92M -46.95M -51.7M -59.19M -85.4M -75.06M -65.23M -91.86M -73.03M -62.99M -135.24M 49.67M -133.84M -70.43M
Depreciation & Amortization
221K 327K 352K 739K 781K 820K 1.88M 2.38M 2.71M 2.96M 2.69M 2.68M 2.65M 2.58M 2.58M 2.59M 4.3M 5.34M